Pharmafile - Medical Communications News
Novartis lands itself in hot water over questionable deal with Trump's lawyer, while UK MPs demand UK pharma be aligned with EU operations post-...
The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was a case of a person...
Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial onset seizures...
The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig is the first CGRP inhibitor to...
A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just as effective after a...
A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure that the pharmaceutical...
The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as it emerges that...
We are in the midst of a breath-taking series of changes in the world of pharmacovigilance, both within Europe and beyond and this has prompted new...
President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry with talk...
In our latest free webinar, listen to Dr William Richardson, Medical Advisor at NDA Group, speak on how to best implement the revised GVP module...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
